Literature DB >> 32711931

Anaplastic large-cell lymphoma (ALK-negative)-related heart failure and recurrence after heart transplantation.

Christopher Felicelli1, Nicolas Lopez-Hisijos1, Reeba Omman1, Daniel Shepherd1, Vijayalakshmi Ananthanarayanan1, Ameet R Kini1, Rhett P Ketterling2, Joseph J Maleszewski2, Elaine S Jaffe3, Sucha Nand4, Joshua Newman5, Ashish Haryani5, Max Liebo5, Kamran M Mirza1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32711931      PMCID： PMC9472705          DOI： 10.1016/j.healun.2020.06.028

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   13.569


× No keyword cloud information.
  10 in total

1.  Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.

Authors:  Gayathri Kumarasinghe; Orly Lavee; Andrew Parker; Ian Nivison-Smith; Samuel Milliken; Anthony Dodds; Joanne Joseph; Keith Fay; David D Ma; Monique Malouf; Marshall Plit; Adrian Havryk; Ann M Keogh; Christopher S Hayward; Eugene Kotlyar; Andrew Jabbour; Allan R Glanville; Peter S Macdonald; John J Moore
Journal:  J Heart Lung Transplant       Date:  2015-06-11       Impact factor: 10.247

Review 2.  Acute antibody-mediated rejection of cardiac transplants.

Authors:  Elaine F Reed; Anthony J Demetris; Elizabeth Hammond; Silviu Itescu; Jon A Kobashigawa; Nancy L Reinsmoen; E Rene Rodriguez; Marlene Rose; Susan Stewart; Nicole Suciu-Foca; Adriana Zeevi; Michael C Fishbein
Journal:  J Heart Lung Transplant       Date:  2006-02       Impact factor: 10.247

3.  Effect of everolimus on skin cancers in calcineurin inhihitor-treated heart transplant recipients.

Authors:  Sylvie Euvrard; Pascale Boissonnat; Ana Roussoulières; Jean Kanitakis; Evelyne Decullier; Alain Claudy; Laurent Sebbag
Journal:  Transpl Int       Date:  2009-11-27       Impact factor: 3.782

4.  Primary cardiac lymphoma: B- and T-cell cases at a specialist UK centre.

Authors:  J Patel; L Melly; M N Sheppard
Journal:  Ann Oncol       Date:  2009-10-21       Impact factor: 32.976

Review 5.  Update on the Treatment of Anaplastic Large Cell Lymphoma.

Authors:  Khoan Vu; Weiyun Ai
Journal:  Curr Hematol Malig Rep       Date:  2018-04       Impact factor: 3.952

6.  Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma.

Authors:  Andre Weilemann; Michael Grau; Tabea Erdmann; Olaf Merkel; Ulduz Sobhiafshar; Ioannis Anagnostopoulos; Michael Hummel; Antje Siegert; Claudia Hayford; Hannelore Madle; Brigitte Wollert-Wulf; Iduna Fichtner; Bernd Dörken; Stephan Dirnhofer; Stephan Mathas; Martin Janz; N C Tolga Emre; Andreas Rosenwald; German Ott; Peter Lenz; Alexandar Tzankov; Georg Lenz
Journal:  Blood       Date:  2014-10-30       Impact factor: 22.113

7.  Cardiac presentation of ALK positive anaplastic large cell lymphoma.

Authors:  Z Y Lim; R Grace; J R Salisbury; D Creamer; A Jayaprakasam; A Y L Ho; S Devereux; G J Mufti; A Pagliuca
Journal:  Eur J Haematol       Date:  2005-12       Impact factor: 2.997

8.  The nucleophosmin-anaplastic lymphoma kinase fusion protein induces c-Myc expression in pediatric anaplastic large cell lymphomas.

Authors:  Elizabeth A Raetz; Sherrie L Perkins; Marlee A Carlson; Kevin P Schooler; William L Carroll; David M Virshup
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

9.  Primary cardiac lymphoma treated with orthotopic heart transplantation: a case report.

Authors:  D D Yuh; S H Kubo; G S Francis; A Bank; K M McDonald; J Jessurun; C Verfaillie; S J Shumway
Journal:  J Heart Lung Transplant       Date:  1994 May-Jun       Impact factor: 10.247

10.  Cardiac anaplastic large cell lymphoma in an 8-year old boy.

Authors:  Melchior Lauten; Simon Vieth; Christopher Hart; Wilhelm Wössmann; Birte Tröger; Christoph Härtel; Martin Bethge; André Schrauder; Gunnar Cario
Journal:  Leuk Res Rep       Date:  2014-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.